Professor, Internal Medicine, Mayo Medical School
Cardiology
Bernard J. Gersh is an expert in the field of Cardiology. He received awards:"James B. Herrick Award for Outstanding Achievement in Clinical Cardiology - Council on Clinical Cardiology", "The Will Fennell Lectureship", "Honorary Fellow", "Henry Dvorkin Memorial Award", "Cardiovascular Fellows Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of Internal Medicine", "Honorary member", "Mention - Who's Who in Medicine and Health Care", "Mention - Who's Who in the World", "Listing, The Best Doctors in America", "8th Annual Thomas E. O'Brien, MD Memorial Lecture Award for Excellence", "Listing, The Best Heart Doctors in America", "Meritorious Service Award", "Osler Award for Teaching", "Listing, The Top Doctors", "Visiting Professor Award for Excellence in Teaching", "Distinctions in Surgery, Psychiatry and Medical Jurisprudence", "Final Year Class Medals in Surgery, Obstetrics and Gynecology", "Moffat Memorial Prize (V) Year for "Academic achievement in Surgery and a wide interest in the humanities"", "Rhodes Scholarship", "Thackeray Prize. Final Year. "Most promising final year student in surgery"" and "Fellow". Bernard Gersh is a published doctor and has 101 publications published. The lastest was: 'Impact of Socioeconomic Status, Ethnicity, and Urbanization on Risk Factor Profiles of Cardiovascular Disease in Africa.' He is registered with Medicare.
Publications
- Anticoagulation for prosthetic heart Valves: unresolved questions requiring answers.
- Typical, Atypical, and Asymptomatic Presentations of New-Onset Atrial Fibrillation in the Community: Characteristics and Prognostic Implications.
- Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
- Pulmonary hypertension is associated with worse survival in hypertrophic Cardiomyopathy.
- The rise, fall, and possible resurrection of renal denervation.
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart Disease.
- Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.
- Angina in Revascularization of Ischemic Cardiomyopathy: The Whole Quilt, or Just a STICH?
- ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!
- Antithrombotic strategies and outcomes in Acute coronary syndrome with atrial fibrillation.
- Heart rate is associated with progression of Atrial fibrillation, independent of rhythm.
- Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to Acute coronary syndrome.
- Potential relief for refractory Angina.
- Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous Coronary intervention: pooled patien...
- Use and Outcomes Associated with Bridging During Anticoagulation Interruptions in Patients with Atrial Fibrillation: Findings from the Outcomes Registry for Better Inf...
- Contemporary Decade Long Trends in Atrial Fibrillation Incidence and Survival: A Community Study.
- Timing of intervention and outcome in non-ST-elevation Acute coronary syndromes: There is risk on both sides of the curve.
- Myectomy Versus Alcohol Septal Ablation: Experience Remains Key.
- Do Current Clinical Trials Meet Society's Needs?: A Critical Review of Recent Evidence.
- Reply: Translation of regenerative technologies into clinical paradigms.
- Impact of Incidental Amyloidosis on the Prognosis of Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy for Left Ventricular Outflow Tract Obstruction.
- Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial...
- Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.
- Untreated aortic valve stenosis identified at the time of Coronary artery bypass grafting: thresholds associated with adverse prognosis.
- Management of symptomatic hypertrophic Cardiomyopathy: pills, alcohol, or the scalpel?
- Lack of Concordance Between Empirical Scores and Physician Assessments of Stroke and Bleeding Risk in Atrial Fibrillation: Results From the Outcomes Registry for Bette...
- Physician practices regarding contraindications to oral anticoagulation in Atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of At...
- Left Atrial Mechanics: Echocardiographic Assessment and Clinical Implications.
- Cell therapy for cardiac repair-lessons from clinical trials.
- Comparison of Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Discharged on Versus Not on Statin Therapy (from the Harmonizing Outcomes With Revas...
- Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic Cardiomyopathy.
- Deformation patterns in genotyped patients with hypertrophic Cardiomyopathy.
- Symptomatic pulmonary hypertension with giant left Atrial v waves after surgical maze procedures: Evaluation by comprehensive hemodynamic catheterization.
- Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better ...
- Use of evidence-based cardiac prevention therapy among outpatients with Atrial fibrillation.
- Antithrombotic strategies in Acute coronary syndrome and atrial fibrillation: A community perspective.
- Outcome of septal myectomy in patients with Fabry's Disease.
- Thirty-year trends in outcomes of percutaneous Coronary interventions in diabetic patients.
- Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic Cardiomyopathy.
- Implantable cardioverter defibrillators in patients with valvular Cardiomyopathy.
- Comparison of Surgical Septal Myectomy to Medical Therapy Alone in Patients With Hypertrophic Cardiomyopathy and Syncope.
- Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI ...
- Comparison of abciximab versus eptifibatide during percutaneous Coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
- Complete versus incomplete revascularization with Coronary artery bypass graft or percutaneous intervention in stable Coronary artery disease.
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Associa...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/Ame...
- Cancer-related deaths among different treatment options in chronic Coronary artery disease: results of a 6-year follow-up of the MASS II study.
- Factors Associated With 30-Day Readmission Rates After Percutaneous Coronary Intervention.
- Incidence and angiographic characteristics of patients with apical ballooning Syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: An Analysis from a ...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/Am...
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Associ...
- Impact of Prehospital Electrocardiogram Protocol and Immediate Catheterization Team Activation for Patients With ST-Elevation-Myocardial Infarction.
- Outcomes registry for better informed treatment of Atrial fibrillation: Rationale and design of ORBIT-AF.
- Diastolic dysfunction in patients undergoing cardiac surgery a pathophysiological mechanism underlying the initiation of new-onset post-operative Atrial fibrillation.
- Is there a role for pre-hospital fibrinolysis in north america?
- Hypertension: a global perspective.
- Rhythm control strategies and the role of antiarrhythmic drugs in the management of Atrial fibrillation: focus on clinical outcomes.
- Utility of left bundle branch block as a diagnostic criterion for Acute myocardial infarction.
- Trends, predictors, and outcomes of cerebrovascular events related to percutaneous Coronary intervention: a 16-year single-center experience.
- CD34(+) cell infusion after ST elevation Myocardial infarction is associated with improved perfusion and is dose dependent.
- Pharmacological facilitation of Coronary intervention in ST-segment elevation myocardial infarction: time is of the essence.
- Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic Cardiomyopathy.
- Risk of all-cause mortality, recurrent myocardial infarction, and Heart failure hospitalization associated with smoking status following myocardial infarction with lef...
- Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel Coronary artery bypass grafting. The MASS III Trial.
- Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivesse...
- Clinical and economic outcomes after introduction of drug-eluting stents.
- When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADIL...
- Interactions between sleep disordered breathing and Atrial fibrillation in patients with hypertrophic cardiomyopathy.
- Impact of delay to angioplasty in patients with Acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Int...
- C-reactive protein, left Atrial volume, and Atrial fibrillation: a prospective study in high-risk elderly.
- Percutaneous revascularization for stable Coronary artery disease temporal trends and impact of drug-eluting stents.
- Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic Cardiomyopathy.
- Chronic Coronary artery disease: diagnosis and management.
- Ethical issues in cardiovascular research involving humans.
- Optimal anticoagulation therapy in patients with valvular heart Disease or atrial fibrillation.
- Histologic characterization of hypertrophic Cardiomyopathy with and without myofilament mutations.
- Cardiac cell repair therapy: a clinical perspective.
- The SYNTAX trial: a perspective.
- New therapies for stroke prevention in Atrial fibrillation: the long road to enhanced efficacy.
- Syncope while driving: clinical characteristics, causes, and prognosis.
- Role of smoking in the recurrence of atrial Arrhythmias after cardioversion.
- Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.
- Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with Acute coronary...
- Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic Cardiomyopathy: a long-term follow-up study.
- Outcome of patients with hypertrophic Cardiomyopathy and a normal electrocardiogram.
- Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic Cardiomyopathy.
- Outcomes of a system-wide protocol for elective and nonelective Coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience.
- Outcomes following pre-operative clopidogrel administration in patients with Acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Cath...
- Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic Cardiomyopathy.
- Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation Acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Int...
- How should hypertrophic Cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic Cardiomyopathy and left ventricular hyper...
- Sex differences in morphology and outcomes of mitral Valve prolapse.
- Images in cardiovascular medicine. Severe left Atrial appendage stunning after electrical cardioversion of Atrial fibrillation.
- Sudden death after Myocardial infarction.
- Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous Coronary intervention (data from the Eva...
- Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux Disease and esophagitis.
- Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial Arrhythmias.
- Should percutaneous revascularization for stable Coronary artery disease be performed sooner or later?
- Effect of septal ablation on myocardial relaxation and left Atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study.
- Impact of Socioeconomic Status, Ethnicity, and Urbanization on Risk Factor Profiles of Cardiovascular Disease in Africa.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- Aortic Valve Disease
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Awards
- James B. Herrick Award for Outstanding Achievement in Clinical Cardiology - Council on Clinical Cardiology
- The Will Fennell Lectureship
- Honorary Fellow
- Henry Dvorkin Memorial Award
- Cardiovascular Fellows Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of Internal Medicine
- Honorary member
- Mention - Who's Who in Medicine and Health Care
- Mention - Who's Who in the World
- Listing, The Best Doctors in America
- 8th Annual Thomas E. O'Brien, MD Memorial Lecture Award for Excellence
- Listing, The Best Heart Doctors in America
- Meritorious Service Award
- Osler Award for Teaching
- Listing, The Top Doctors
- Visiting Professor Award for Excellence in Teaching
- Distinctions in Surgery, Psychiatry and Medical Jurisprudence
- Final Year Class Medals in Surgery, Obstetrics and Gynecology
- Moffat Memorial Prize (V) Year for "Academic achievement in Surgery and a wide interest in the humanities"
- Rhodes Scholarship
- Thackeray Prize. Final Year. "Most promising final year student in surgery"
- Fellow
Education
-
Mayo School of Graduate Medical Education
-
University of Cape Town Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1245219237 |
| Last Name Of The Provider |
GERSH |
| First Name Of The Provider |
BERNARD |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.